Unveiling bioanalytical datasets for the successful development of ADCsBy Taylor & Francis Group

Bridging science and safety: exploring toxicology studies and regulatory requirementsBy Taylor & Francis Group

This International Women’s Day, we’re joined by Lindsay Davies, Chief Scientific Officer at NextCell Pharma (Stockholm, Sweden), to discuss the evolving role of cell therapies in treating autoimmune diseases.In this podcast, Davies breaks down the science behind NextCell’s mesenchymal stromal cell therapy for type 1 diabetes and explores how these …

During the American Association of Pharmaceutical Scientists (AAPS) PharmSci 360 2024 conference, Bioanalysis Zone caught up with industry experts across numerous disciplines to discuss their involvement with AAPS and their research. In this interview, we spoke to Priyata Kalra about her talk on the use of GenAI within biomedicine.…

In this episode, we sit down with Megan Cooley, Associate Director of Bioanalytical Services at ICON (KS, USA), to explore the cutting-edge world of antibody-drug conjugate (ADC) quantitation using high-resolution mass spectrometry (HRMS). Megan delves into the capabilities of Triple Quadrupole and Time-of-Flight mass spectrometry, offering her exp…

In this interview, we discuss the potential of AI in increasing healthcare system efficiency, how medical devices are making procedures less invasive and what those working in the field of medical devices can do to help regulation catch up with innovation.By Taylor & Francis Group

In the sixth episode of The new frontier podcast, we're joined by Catherine Vrentas, Life Sciences Lead at Booz Allen Hamilton (VA, USA). Cathy explains how biomarkers can be used to predict the therapeutic outcome and efficacy of CGTs and the biomarkers in particular that have shown strong predictive value. We delve into the common challenges of w…

Carlon Fitzpatrick AI Summit by Taylor & Francis GroupBy Taylor & Francis Group

Challenges and solutions in monitoring assay performance for vaccine development: an interview with Atul ChaudhariBy Taylor & Francis Group

We caught up with Principal Scientist Lindsay Denhoff (ICON; Dublin, Ireland) to discuss immunogenicity considerations for therapeutic proteins and the current analytical methodologies for detecting and characterizing anti-drug antibodies (ADAs). Lindsay shares some industry best practices for achieving high-quality ADA assays, as well as some of t…

In this Tech Blast episode supported by Sartorius (Göttingen, Germany), we speak with David Apiyo – Manager of Applications Development at Sartorius (MN, USA) – about epitope binning, why it's performed and the best ways to conduct it. Plus, learn more about Sartorius' biolayer interferometry platforms and their application in epitope binning.…

In this interview, we spoke to John Chappell, Senior Global Scientific Support Manager at Gyros Protein Technologies (Uppsala, Sweden) about his experience working with the Gyrolab platform for oligonucleotide assays. John discusses the advantages of using Gyrolab for oligo quantification in biological fluids and shares his thoughts on the next ste…

In the fifth episode of The New Frontier podcast, we're joined by Paul Byrne, Senior Director of Genomics from ProtaGene (MA, USA). Paul describes his experience working with qPCR vs digital and digital droplet PCR assays and advises on their pros and cons, as well as when it's best to use each. We discuss how these assays can be optimized for cell…

In this episode of The New Frontier podcast, we're joined by Daniel Schulz-Jander, Senior Director of Mass spectrometry Bioanalysis at QPS Netherlands (Groningen). Daniel explains how he uses immune-precipitation and immunoaffinity LC–MS techniques for his work relating to macromolecular pharmaceuticals like gene therapies, as well as their benefit…

Breaking down barriers for women in tech: an interview with Tina Marshall by Taylor & Francis GroupBy Taylor & Francis Group

What disparities exist in cancer screening and how does this impact patient outcomes? Listen to our latest podcast episode with Kilan Ashad-Bishop (American Cancer Society) to find out about the intersection between science, health, and society.By Taylor & Francis Group

AI-driven early disease detection: an interview with Jim Kean by Taylor & Francis GroupBy Taylor & Francis Group

In this episode, we spoke to Senior Director Johanna Mora about her experience with immunogenicity testing for cell and gene therapies (CGTs) and how she prepared for the expansion of BMS's portfolio to include CGTs. We discuss the importance of having diverse teams with a broad range of experiences to solve complex problems, as well as the role of…

In the first episode of this series, we spoke to Executive Director and Global Head of Regulatory Services Kimberley Buytaert-Hoefen about her experience with cell and gene therapy (CGT) approvals and the barriers to getting these important therapeutics to the patient. Kim advises early regulatory interaction and collaboration to improve the succes…

AI and the UK Biobank: an interview with Mahesh PancholiBy Taylor & Francis Group

In our new podcast series, we're joined by a Bioanalysis author to review their publication's biggest challenges, wider implications and next steps. In the final episode of series one, we're joined by Hetal Sarvaiya and Yuting Wang from AbbVie (MA, USA), who talk about the challenges of having an international team working on their perspective arti…

Virtual reality therapies for mental health: Marta Matamala-GomezBy Taylor & Francis Group

An interview with Namshik Han: predicting protein structure with AIBy Taylor & Francis Group

In this Tech Blast episode supported by Sartorius, we speak with Derrick Christopher Campos, Product Manager at Sartorius (TX, USA), about Surface Plasmon Resonance (SPR). This tried-and-true technique allows researchers to do label-free protein characterization; in this podcast, Derrick discusses how Sartorius improves upon multi-cycle kinetics wi…

In our new podcast series, we're joined by a Bioanalysis author to review their publication's biggest challenges, wider implications and next steps. In episode four, we're joined by Senior Scientist and Technical Specialist Ashley Phillips. Ashley's publication assessed the performance of next-generation trypsins for rapid protein LC-MS bioanalysis…

In our new podcast series, we're joined by a Bioanalysis author to review their publication's biggest challenges, wider implications and next steps. In episode three, Digital Editor Ellen Williams is joined by Clinical Instructor and Education Coordinator Camilla Linder and Biomedical Laboratory Scientist Miguel Gambell Barroso. The collaborative p…

An interview with Walt Szablowski: how should healthcare systems handle cybersecurity breaches? by Taylor & Francis GroupBy Taylor & Francis Group

In this episode of Talking Techniques, Ritwika Biswas, Field Scientist at Sino Biological US Inc. (PA, USA), walks us through the chimeric antigen receptor (CAR) development process and how T and natural killer (NK) cells can be utilized to carry these modular synthetic molecules. Ritwika also addresses the safety and efficacy of these cell therapi…

AI Summit 2023: an interview with Phalgun Lolur by Taylor & Francis GroupBy Taylor & Francis Group

Brain-computer interfaces and neuroethics with Uthman Ali by Taylor & Francis GroupBy Taylor & Francis Group

In this Tech Blast episode, we explore preparing 3D cell cultures with Sartorius’ (Goettingen, Germany) Sandra Söderholm, Application Development Specialist, and Maria Voutilainen, Product Manager. Sandra and Maria give us an introduction to 3D cell cultures and how to prepare them, and then delve into a foundational technique that is often overloo…

In our new podcast series, we're joined by a Bioanalysis author to review their publication's biggest challenges, wider implications and next steps. In episode two, Ellen is joined by Research Assistant Gaudry Troché to discuss conventional sampling and microsampling for the comparison of pharmacokinetic study profiles of insulin. Gaudry discusses …

In this episode of Talking Techniques, Ritwika Biswas, Field Scientist at Sino Biological US Inc., walks us through the chimeric antigen receptor (CAR) development process and how T and natural killer (NK) cells can be utilized to carry these modular synthetic molecules. Ritwika also addresses the safety and efficacy of these cell therapies as well…

Lance - Interview - FINAL by Taylor & Francis GroupBy Taylor & Francis Group

Luciano Floridi Interview Final by Taylor & Francis GroupBy Taylor & Francis Group

In this episode, supported by Fortis Life Sciences, we delve into the relationship between mitochondria, inflammation and cancer, discussing the new techniques that are bearing fruit in this field, such as spatial analysis.Our expert insight for this episode comes from Phillip West, Principle Investigator of the West lab at Texas A&M Medicine (TX, …

Intelligent health systems: an interview with Mazin Gadir by Taylor & Francis GroupBy Taylor & Francis Group

In this Tech Blast episode supported by CN Bio (Cambridge, UK), their Lead Scientist Emily Richardson and Principal Bioengineer Dharaminder Singh talk us through organ-on-a-chip (OOC) technologies. From what they are and how they work to what kind of data they provide and their future applications, Emily and Dharaminder provide all the information …

In our new podcast series, we're joined by a Bioanalysis author to review the publication's biggest challenges, wider implications and next steps. In this first episode, we're joined by early career Researcher Anthony Breton to discuss volumetric absorptive microsampling (VAMS®) as an alternative to venepuncture for the assessment of essential and …

Mixed reality technologies in medical and surgical applications: an interview with Taylor KantorBy Taylor & Francis Group

In this episode, sponsored by Zymo Research, we explore the microbiome and how long-read sequencing techniques are changing our approach to the field and the exciting discoveries that they have led to. To do this we speak to Kris Locken, Molecular Biologist in the Research & Development department of Zymo Research (CA, USA), and Jeremy Wilkinson, G…

About Matt Kurth Matt Kurth, an expert in tourism and recreation, is the founder and Chief Executive Officer of Humboldt Cannabis Tours. From day one, Matt wanted to provide more than a California cannabis farm tour by safely connecting consumers with producers. His wealth of knowledge on all things Emerald Triangle led to the creation of a company…

Skip Stone Bio: An experienced and successful leader in Business Development and fundraising. Proficient in complicated Municipal Government sales, team management, equipment procurement, industrial equipment startup, shakedown, and installation, research and development (R&D), social media management, product design, supply chain management, sourc…

Autumn Karcey Bio: Title: CEO Over the past eighteen years, Ms. Karcey has honed her skills in many aspects of the cannabis industry including permit acquisition, cultivation, facility design, and environmental optimization. As one of Los Angeles’s leading medicinal cannabis cultivators for over a decade, a model that created a zero-tolerance for c…

Title: CEO A visionary known for her “wow” factor and steely determination, Tracee artfully blends impressive industry experience and moxie with a passion for cannabis medicine. Tracee brings a lively flair to all undertakings, sharing her intuition, awareness, and experience in a style all her own. By envisioning, developing and executing products…

About Kevin Nafte: As a global citizen, Kevin has lived in South Africa, Australia, Israel and the US where he was Head of Operations at Flow Kana, one of California's biggest cannabis distributors. Today, Kevin lives in Uruguay where, together with his wife and cofounder, Andrea Kruchik Krell, are pioneering a sustainable cannabis industry. Kevin …

Nathan Johnson Ph.D. Bio: Dr. Johnson currently serves as the CEO and co-owner of Verne Bioanalytics LLC, an innovator in cannabis and hemp genetic and pathogen analysis. Verne Bioanalytics provides testing services directly as well as self-administered test kits for cultivators to rapidly detect pathogens, identify unwanted male plants, predict ca…

Cody Callarman: A Marine Veteran that dropped everything I had to build the hemp/cannabis industry in South Carolina. 15+ years in leadership and 12+ years as a business owner. Zitro Farm's is South Carolina's premium indoor CBD flower cultivator. We started out our journey in 2020. In the years since hemp farming has become legal, we saw that Sout…